Stocksigma LogoStocksigma Logo

Q-Line Biotech Clarifies NSE Fine and Seeks Waiver on Technical Filing Delay

Q-Line Biotech Limited submitted board comments regarding a Rs 11,800 fine (including 18% GST) levied by NSE under Regulation 44(3) for delayed XBRL voting

Q-Line Biotech Clarifies NSE Fine and Seeks Waiver on Technical Filing Delay

Q-Line Biotech Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 1:40 am

Q-Line Biotech Clarifies NSE Fine and Seeks Waiver on Technical Filing Delay Q-Line Biotech Limited submitted board comments regarding a Rs 11,800 fine (including 18% GST) levied by NSE under Regulation 44(3) for delayed XBRL voting results for Sep'26. The company clarified that voting results and the Scrutinizer鈥檚 Report in PDF format were timely submitted on 1st Oct'26, but NEAPS portal technical glitches delayed the XML filing until 7th Oct'26. Following NSE鈥檚 14th Oct'26 notice, the company paid the fine and requested a waiver or refund, citing absence of intentional default and strengthened internal maker-checker compliance mechanisms.

Original exchange filing (PDF)

More announcements from Q-Line Biotech Ltd

All Q-Line Biotech Ltd announcements